Autocrine inhibitory influences of α-melanocyte-stimulating hormone in malignant pleural mesothelioma

Anna Catania, Gualtiero Colombo, Andrea Carlin, Letizia Garofalo, Stefano Gatti, Roberto Buffa, Nadia Carboni, Lorenzo Rosso, Luigi Santambrogio, Luigi Cantalamessa, James M. Lipton

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Malignant pleural mesothelioma is a highly aggressive tumor arising from the mesothelial cells that line the pleural cavities. This tumor is resistant to most conventional anticancer treatments and appears to be very sensitive to growth-promoting influences of cytokines and growth factors. Identification of natural inhibitory pathways that control growth should aid discovery of novel therapeutic approaches. We hypothesized that α-melanocyte-stimulating hormone (α-MSH), which is produced by many cell types and antagonizes cytokines and growth factors, could be an endogenous inhibitory molecule in mesothelioma. Twelve mesothelioma cell lines were established from pleural effusions of patients with malignant mesothelioma. Mesothelioma cells were found to express mRNA for proopiomelanocortin and its processing enzymes; release α-MSH peptide into supernatants; and express melanocortin 1 receptor (MC1R), the high-affinity receptor for α-MSH. Immunoneutralization of MC1R in the cell lines enhanced expression of interleukin-8 (IL-8), IL-6, and transforming growth factor-β. These molecules promote mesothelioma proliferation and are considered therapeutic targets in this tumor. Coincubation of mesothelioma cells with synthetic α-MSH significantly reduced cell proliferation. The present research shows an autocrine-inhibitory circuit based on α-MSH and its receptor MC1R. Activation of MC1R by selective peptides or peptidomimetics might provide a novel strategy to reduce mesothelioma cell proliferation by taking advantage of this endogenous inhibitory circuit.

Original languageEnglish
Pages (from-to)253-259
Number of pages7
JournalJournal of Leukocyte Biology
Volume75
Issue number2
DOIs
Publication statusPublished - Feb 2004

Fingerprint

Melanocyte-Stimulating Hormones
Mesothelioma
Receptor, Melanocortin, Type 1
Cell Line
Intercellular Signaling Peptides and Proteins
Cell Proliferation
Cytokines
Peptidomimetics
Artificial Cells
Pleural Cavity
Neoplasms
Pro-Opiomelanocortin
Peptides
Transforming Growth Factors
Pleural Effusion
Growth
Interleukin-8
Malignant Mesothelioma
Interleukin-6
Therapeutics

Keywords

  • Growth factors
  • Malignant mesothelioma
  • Melanocortin receptors (MCR)
  • Proopiomelanocortin (POMC)

ASJC Scopus subject areas

  • Cell Biology

Cite this

Autocrine inhibitory influences of α-melanocyte-stimulating hormone in malignant pleural mesothelioma. / Catania, Anna; Colombo, Gualtiero; Carlin, Andrea; Garofalo, Letizia; Gatti, Stefano; Buffa, Roberto; Carboni, Nadia; Rosso, Lorenzo; Santambrogio, Luigi; Cantalamessa, Luigi; Lipton, James M.

In: Journal of Leukocyte Biology, Vol. 75, No. 2, 02.2004, p. 253-259.

Research output: Contribution to journalArticle

Catania, Anna ; Colombo, Gualtiero ; Carlin, Andrea ; Garofalo, Letizia ; Gatti, Stefano ; Buffa, Roberto ; Carboni, Nadia ; Rosso, Lorenzo ; Santambrogio, Luigi ; Cantalamessa, Luigi ; Lipton, James M. / Autocrine inhibitory influences of α-melanocyte-stimulating hormone in malignant pleural mesothelioma. In: Journal of Leukocyte Biology. 2004 ; Vol. 75, No. 2. pp. 253-259.
@article{4661bea1457844439ed96b978566a1b7,
title = "Autocrine inhibitory influences of α-melanocyte-stimulating hormone in malignant pleural mesothelioma",
abstract = "Malignant pleural mesothelioma is a highly aggressive tumor arising from the mesothelial cells that line the pleural cavities. This tumor is resistant to most conventional anticancer treatments and appears to be very sensitive to growth-promoting influences of cytokines and growth factors. Identification of natural inhibitory pathways that control growth should aid discovery of novel therapeutic approaches. We hypothesized that α-melanocyte-stimulating hormone (α-MSH), which is produced by many cell types and antagonizes cytokines and growth factors, could be an endogenous inhibitory molecule in mesothelioma. Twelve mesothelioma cell lines were established from pleural effusions of patients with malignant mesothelioma. Mesothelioma cells were found to express mRNA for proopiomelanocortin and its processing enzymes; release α-MSH peptide into supernatants; and express melanocortin 1 receptor (MC1R), the high-affinity receptor for α-MSH. Immunoneutralization of MC1R in the cell lines enhanced expression of interleukin-8 (IL-8), IL-6, and transforming growth factor-β. These molecules promote mesothelioma proliferation and are considered therapeutic targets in this tumor. Coincubation of mesothelioma cells with synthetic α-MSH significantly reduced cell proliferation. The present research shows an autocrine-inhibitory circuit based on α-MSH and its receptor MC1R. Activation of MC1R by selective peptides or peptidomimetics might provide a novel strategy to reduce mesothelioma cell proliferation by taking advantage of this endogenous inhibitory circuit.",
keywords = "Growth factors, Malignant mesothelioma, Melanocortin receptors (MCR), Proopiomelanocortin (POMC)",
author = "Anna Catania and Gualtiero Colombo and Andrea Carlin and Letizia Garofalo and Stefano Gatti and Roberto Buffa and Nadia Carboni and Lorenzo Rosso and Luigi Santambrogio and Luigi Cantalamessa and Lipton, {James M.}",
year = "2004",
month = "2",
doi = "10.1189/jlb.0603264",
language = "English",
volume = "75",
pages = "253--259",
journal = "Journal of Leukocyte Biology",
issn = "0741-5400",
publisher = "FASEB",
number = "2",

}

TY - JOUR

T1 - Autocrine inhibitory influences of α-melanocyte-stimulating hormone in malignant pleural mesothelioma

AU - Catania, Anna

AU - Colombo, Gualtiero

AU - Carlin, Andrea

AU - Garofalo, Letizia

AU - Gatti, Stefano

AU - Buffa, Roberto

AU - Carboni, Nadia

AU - Rosso, Lorenzo

AU - Santambrogio, Luigi

AU - Cantalamessa, Luigi

AU - Lipton, James M.

PY - 2004/2

Y1 - 2004/2

N2 - Malignant pleural mesothelioma is a highly aggressive tumor arising from the mesothelial cells that line the pleural cavities. This tumor is resistant to most conventional anticancer treatments and appears to be very sensitive to growth-promoting influences of cytokines and growth factors. Identification of natural inhibitory pathways that control growth should aid discovery of novel therapeutic approaches. We hypothesized that α-melanocyte-stimulating hormone (α-MSH), which is produced by many cell types and antagonizes cytokines and growth factors, could be an endogenous inhibitory molecule in mesothelioma. Twelve mesothelioma cell lines were established from pleural effusions of patients with malignant mesothelioma. Mesothelioma cells were found to express mRNA for proopiomelanocortin and its processing enzymes; release α-MSH peptide into supernatants; and express melanocortin 1 receptor (MC1R), the high-affinity receptor for α-MSH. Immunoneutralization of MC1R in the cell lines enhanced expression of interleukin-8 (IL-8), IL-6, and transforming growth factor-β. These molecules promote mesothelioma proliferation and are considered therapeutic targets in this tumor. Coincubation of mesothelioma cells with synthetic α-MSH significantly reduced cell proliferation. The present research shows an autocrine-inhibitory circuit based on α-MSH and its receptor MC1R. Activation of MC1R by selective peptides or peptidomimetics might provide a novel strategy to reduce mesothelioma cell proliferation by taking advantage of this endogenous inhibitory circuit.

AB - Malignant pleural mesothelioma is a highly aggressive tumor arising from the mesothelial cells that line the pleural cavities. This tumor is resistant to most conventional anticancer treatments and appears to be very sensitive to growth-promoting influences of cytokines and growth factors. Identification of natural inhibitory pathways that control growth should aid discovery of novel therapeutic approaches. We hypothesized that α-melanocyte-stimulating hormone (α-MSH), which is produced by many cell types and antagonizes cytokines and growth factors, could be an endogenous inhibitory molecule in mesothelioma. Twelve mesothelioma cell lines were established from pleural effusions of patients with malignant mesothelioma. Mesothelioma cells were found to express mRNA for proopiomelanocortin and its processing enzymes; release α-MSH peptide into supernatants; and express melanocortin 1 receptor (MC1R), the high-affinity receptor for α-MSH. Immunoneutralization of MC1R in the cell lines enhanced expression of interleukin-8 (IL-8), IL-6, and transforming growth factor-β. These molecules promote mesothelioma proliferation and are considered therapeutic targets in this tumor. Coincubation of mesothelioma cells with synthetic α-MSH significantly reduced cell proliferation. The present research shows an autocrine-inhibitory circuit based on α-MSH and its receptor MC1R. Activation of MC1R by selective peptides or peptidomimetics might provide a novel strategy to reduce mesothelioma cell proliferation by taking advantage of this endogenous inhibitory circuit.

KW - Growth factors

KW - Malignant mesothelioma

KW - Melanocortin receptors (MCR)

KW - Proopiomelanocortin (POMC)

UR - http://www.scopus.com/inward/record.url?scp=10744228408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744228408&partnerID=8YFLogxK

U2 - 10.1189/jlb.0603264

DO - 10.1189/jlb.0603264

M3 - Article

C2 - 14576363

AN - SCOPUS:10744228408

VL - 75

SP - 253

EP - 259

JO - Journal of Leukocyte Biology

JF - Journal of Leukocyte Biology

SN - 0741-5400

IS - 2

ER -